What's new in IDIS:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Advisory Committee Meetings

 • Continuing Education Articles

 • Priority Clinical Practice Guidelines

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

Notice: IDIS database discontinuation December 31, 2014.   Read more.

IDIS Logo   IDIS Monthly Update Information - December 2012

NEW DRUG TERM
AMG-145
BAY-794980
BITOPERTIN
CHOLINE C-11
CYCLIC PYRANOPTERIN MONOPHOS
ENTEROVIRUS 71 VACCINE
INSULIN PEGLISPRO
IODINE I 124 IOBENGUANE
PF-04523655
RONTALIZUMAB
ROZROLIMUPAB
SWEET CLOVER

CODE
82000573
20121626
28160889
78042001
92000387
80120108
68200878
78040429
14000087
82000572
82000009
92510290



DRUG NAME/CODE CHANGES

OLD TERM & CODE
INS-365 92000065

NEW TERM & CODE
DIQUAFOSOL 92000065


FDA APPROVAL PACKAGES

Article Numbers 687718-687731: Teriflunomide, Aubagio, FDA Approval Package for NDA 202992. FDA Approval Package 2012.

Article Numbers 687701-687717: Omacetaxine Mepesuccinate, Synribo, FDA Approval Package for NDA 203585. FDA Approval Package 2012.


ADVISORY COMMITTEE MEETINGS

Article Numbers 687732-687738: Endocrinologic and Metabolic Drugs Advisory Committee Meeting, October 17, 2012. FDA Advisory Committee 2012.


CONTINUING EDUCATION ARTICLES

Article Number 688018: Bugos K G, Dunn J D. Multiple Myeloma: Supportive Care Requirements and Coordination of Patient-Centered Care (0.15 CEU) [IDIS Note: The 1.5 Hour of CE Credit is for All Articles in this Issue, Article Numbers 688016-688018]. J Manag Care Pharm 2012, 18:S20-S25.

Article Number 688017: Mullins C D, Dunn J D. Applying Oncology Formulary and Benefit Design Innovations to the Management of Multiple Myeloma in the Managed Care Setting (0.15 CEU) [IDIS Note: The 1.5 Hour of CE Credit is for All Articles in this Issue, Article Numbers 688016-688018]. J Manag Care Pharm 2012, 18:S13-S19.

Article Number 688016: Huff C A, Dunn J D. Identifying Indicators of Outcomes and Implementing Treatment Pathways (0.15 CEU) [IDIS Note: The 1.5 Hour of CE Credit is for All Articles in this Issue, Article Numbers 688016-688018]. J Manag Care Pharm 2012, 18:S5-S12.

Article Number 688015: Anonymous. Linaclotide (Linzess) for Constipation (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 688014 and 688015]. Med Lett Drugs Ther 2012, 54:91-92.

Article Number 688014: Anonymous. New Drugs for Multiple Sclerosis (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 688014 and 688015]. Med Lett Drugs Ther 2012, 54:89-91.

Article Number 688012: Anonymous. Pneumococcal Vaccine for Adults (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 688011 and 688012]. Med Lett Drugs Ther 2012, 54:87-88.

Article Number 688011: Anonymous. Azelastine/Fluticasone Propionate (Dymista) for Seasonal Allergic Rhiniti s (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 688011 and 688012]. Med Lett Drugs Ther 2012, 54:85-87.

Article Number 688009: Anonymous. In Brief: Effervescent Alendronate (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 688007-688009]. Med Lett Drugs Ther 2012, 54:84.

Article Number 688008: Anonymous. Fish Oil Supplements (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 688007-688009]. Med Lett Drugs Ther 2012, 54:83-84.

Article Number 688007: Anonymous. Drugs for Hepatitis C (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 688007-688009]. Med Lett Drugs Ther 2012, 54:81-82.

Article Number 687597: Cada D J, Levien T L, Baker D E. Lorcaserin Hydrochloride (0.15 CEU). Hosp Pharm 2012, 47:871-879.

Article Number 687530: Anonymous. Drugs for Some Common Eye Disorders (0.2 CEU). Treat Guidel Med Lett 2012, 10:79-86.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 687912: Qaseem A, Fihn S D, Dallas P, Williams S, et al. Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American ... (Ref Art 687913). Ann Intern Med 2012, 157:735-743.

Article Number 686768: Authors/Task Force M, Camm A J, Lip G Y, De Caterina R, et al. 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation: An Update of the 2010 ESC Guidelines for the Management of Atrial Fibrillation * Developed with the Special Contribution of The Eur Heart J 2012, 33:2719-2747.

Article Number 686484: Rocco M V, Berns J S. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis 2012, 60:850-886.


College of Pharmacy